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We tested the hypothesis that, in the acute phase of ST-segment elevation myocardial infarction 
(STEMI), the circulating level of P-selectin (PS) is predictive of angiographic morphologic features that 
indicate burden of thrombus formation in the infarct-related artery (IRA). One hundred and ninety-five 
consecutive patients with acute myocardial infarction (AMI) who underwent primary percutaneous 
coronary intervention (PCI) within 12 h of symptom onset were divided into the high-burden thrombus 
formation (HBTF) (N = 84) group and low-burden thrombus formation (LBTF) group (N = 111) based on 
cineangiography carried out during PCI. Blood samples for measurement of the circulating levels of 
high-sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), soluble intercellular cell adhesion 
molecule-1 (sICAM-1), PS and white blood cell (WBC) count were collected before PCI. The WBC count, 
neutrophil granulocyte count and PS level were significantly higher in the HBTF group than in the LBTF 
group (11.24 ± 3.62 vs 10.00 ± 3.35, p = 0.014; 8.84 ± 3.42 vs 7.66 ± 3.23, p = 0.015; 13.62 ± 8.13 vs 7.80 ± 4.17, p 
= 0.000, respectively). Patients in the HBTF group had a significantly lower prevalence of post-PCI 
thrombolysis in myocardial infarction (TIMI) grade-3 flow than that of the LBTF group (84.52% vs 
93.69%, p = 0.037). Compared with the LBTF group, the HBTF group had higher peak values of the 
myocardial band (MB) fraction of creatine kinase (CK-MB). (308.52 ± 215.26 vs 213.79 ± 185.27, p = 
0.005). By logistic regression analysis, PS (OR 1.259, 95%CI 1.125 - 1.408, p = 0.000) were independent 
predictors of thrombus formation. PS level was the strongest independent predictor of angiographic 
morphologic features that indicate HBTF in AMI.  
 





Platelets play a crucial part in the pathogenesis of acute 
coronary syndrome (ACS). Activated platelets adhere to 
the vessel wall at the site of a ruptured plaque and initiate 
formation of an arterial thrombus, which leads to 
ischemia or infarction (Théroux and Fuster, 1998; Gawaz, 
2004; Yip et al., 2004). Increasing evidence suggests that 
markers of platelet activation can be used to identify 
disease activity (Kabbani et al., 2001; Yip et al., 2005). P-
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activated platelets and endothelial cells. PS is important 
in modulating the interaction of these cells with neu-
trophils and monocytes, In platelets, PS is rapidly 
translocated to the platelet surface after stimulation and 
is up-regulated in fresh thrombi, thereby contributing to 
thrombus formation (Hsu-Lin et al., 1984; Carlos and 
Harlan, 1998; Frenette et al., 1995; Gamble et al., 1990). 
Studies have indicated that PS mediates the accu-
mulation of leukocytes, which in turn promotes fibril 
deposition (Palabrica et al., 1992). Other authors have 
shown that PS expression on platelets determines the 
aggregate size and stability of platelets (Merten and 
Thiagarajan, 2000). 





artery (IRA) usually has a high burden of thrombus 
formation (HBTF) (Yip et al., 2001). A link between the 
angiographic morphologic features that indicate HBTF 
and the slow/no-reflow phenomenon has been demon-
strated (Yip et al., 2002). Even if there is thrombolysis in 
myocardial infarction (TIMI) grade-3 flow in the IRA with 
HBTF, some patients may not achieve effective myocardial 
perfusion because of the micro-cardiovascular disease. 
Little is known about the predictors of thrombus formation 
in patients with acute myocardial infarction (AMI). Identi-
fying these predictive factors is very important because it 
will help to pinpoint high-risk patients likely to benefit from 
intensive medical therapy. 
We tested the hypothesis that, in AMI, the levels of white 
blood cells (WBCs) and PS are predictive of angiographic 
morphologic features that indicate HBTF in the IRA of 




MATERIALS AND METHODS 
 
Approval of the study protocol 
 
This study was approved by the Ethics Committee of Xuanwu Hospital. 




Study population and inclusion criteria 
 
All patients in the Cardiology unit of the Department of Xuanwu 
Hospital (Capital Medical University, Beijing, China) with STEMI of 
duration <12 h were considered eligible for primary percutaneous 
coronary intervention (PCI). The angiographic morphologic features 
of the IRA that indicate HBTF (Yip et al., 2002) are defined as: (i) 
An angiographic thrombus with a greatest linear dimension that is 
more than three fold the reference lumen diameter (RLD); (ii) a 
cutoff pattern (that is, lesion morphology with an abrupt cutoff without 
tapering before the occlusion); (iii) an accumulated thrombus (> 5 
mm of linear dimension) proximal to the occlusion; (iv) a floating 
thrombus proximal to the occlusion; (v) persistent dye stasis distal 
to the obstruction; and (vi) RLD of the IRA  4.0 mm. It was defined 
as low burden of thrombus formation (LBTF) without angiographic 
morphologic features of the IRA above. 
We drew-up specific exclusion criteria to avoid other variables that 
could influence the circulating levels of markers of inflammation and 
blood coagulation. We excluded patients: (i) Who had surgery or 
trauma within the preceding 2 months; (ii) with renal insufficiency 
(creatinine > 1.5 mg/dL), malignancy or liver cirrhosis, febrile disorders, 
acute or chronic inflammatory disease on study entry or a recent 
history of infection; (iii) with AMI onset   12 h; who had used 
antiplatelet agents for >3 days before AMI.  
From May 2007 to April 2008, 195 patients (84 patients with 
HBTF and 111 patients with LBTF) were enrolled in the study.  
 
 
Definitions and data collection 
 
AMI was defined as typical chest pain lasting for >30 min with ST 
segment elevation (ST-SE) >1 mm in two or more consecutive 
precordial or inferior leads. Procedural success was defined as 
successful primary PCI with residual stenosis of the index lesions 
<20% after stent deployment and a final TIMI flow of grade 3 in the 
IRA. Detailed in-hospital and follow-up data (age, sex, coronary risk  




factors, serial levels of MB fraction of creatine kinase (CK-MB), 
WBC count, platelet count, creatinine level, echocardiography, 
angiographic findings) were collected prospectively and entered 
into a computerized database. 
 
 
Procedure and protocol 
 
A transradial artery approach using a 6-F arterial sheath is routinely 
used for treatment of AMI in our hospital unless the Allen’s test for 
both hands is positive. A 6-F Kimny guiding catheter (Boston 
Scientific Scimed Incorporated, Maple Grove, MN, USA) was used 
for diagnosis and primary PCI. Clopidogrel (preoperative loading 
dose of 300 mg, then 75 mg/day) was given for at least one year to 
patients who underwent primary stenting. Aspirin (preoperative 
loading dose of 300 mg, then 100 mg/day) was given to each patient  
 
 
Analyses of blood samples 
 
Blood samples were obtained by venous puncture as soon as 
diagnosis of STEMI was made in the Emergency Department of 
Xuanwu Hospital. WBC count and platelet count were determined 
by standard laboratory methods. The concentration of highly 
sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), inter-
cellular adhesion molecule (ICAM) and PS in plasma was determined 
in duplicate using a standard enzyme-linked immunosorbent assay 
(ELISA) and a commercial kit (R&D Systems, Minneapolis, MN, 
USA) according to manufacturer’s instructions. Intra-individual 
variation of these levels was assessed in the study patients, the 





Clinical information regarding major adverse events, including any-
cause death, re-infarction, heart failure requiring hospitalization, or 
stroke, was obtained during the hospitalization. Heart failure was 
defined as a hospital readmission for which heart failure was the 
primary reason. Stroke was defined as a new focal neurological 
deficit of sudden onset lasting 24 h that was caused by hemorrhage 
or ischemia with corroborative imaging evidence by computed 





Results are number (%) or the mean ± SD. Comparisons between 
groups were done using Student’s t-test for continuous variables 
and the chi-square test for categorical variables. p < 0.05 was 
considered significant. Multivariate logistic analysis was done to 
identify independent predictors for thrombi. All variables with p < 
0.05 in the univariate analysis were tested. All calculations were 
carried out using the statistical package for the social sciences 
(SPSS) 13.0 for Windows statistical program (SPSS, Incorporated, 







The baseline data for the study population are shown in 
Table 1. Significant differences between the groups with 
respect to mean age, sex, levels of creatinine, platelet, 
hs-CRP, IL-6, soluble intercellular adhesion molecule 




Table 1. Baseline characteristics of patients. 
 
Characteristic HBTF group (n = 84) LBTF group (n = 111) P 
Age, (y) 59.9 ± 12.8 62.1 ± 12.4 0.812 
Males, n (%) 69 (82.1%) 87 (78.4%) 0.515 
Hypertension, n (%) 50 (59.5%) 69 (62.2%) 0.230 
Diabetes mellitus, n (%) 21 (25.0%) 22 (19.8%) 0.388 
Current smokers, n (%) 56 (66.7%) 73 (65.7%) 0.895 
Glucose (mmol/L) 9.50 ± 4.50 8.53 ± 3.94 0.106 
WBC (109/L) 11.24 ± 3.62 10.00 ± 3.35 0.014 
Neu (109/L) 8.84 ± 3.42 7.66 ± 3.23 0.015 
Platelets (109/L) 256.46 ± 63.27 253.18 ± 73.31 0.743 
hsCRP (mg/L) 6.50 ± 5.18 5.68 ± 4.98 0.452 
IL-6 (pg/mL) 10.32 ± 13.10 8.74 ± 12.91 0.472 
sICAM (ng/mL) 19.28 ± 9.50 19.44 ± 8.51 0.911 
PS (ng/mL) 13.62 ± 8.13 7.80 ± 4.17 0.000 
Time of door to balloon (h) 4.08 ± 2.50 4.55 ± 2.72 0.237 
LVEF (%) 54.31 ± 10.85 56.34 ± 10.85 0.232 
E/A  1.15 ± 0.56 1.06 ± 0.49 0.334 
Peak CK-MB (ng/mL)  308.52 ± 215.26 213.79 ± 185.27 0.005 
Post-PCI TIMI-3 flow, n (%) 71 (84.52%) 104 (93.69%) 0.037 
MACE, n (%) 1 (1.2%) 1 (0.9%) 0.842 
 
WBC: White blood cell; Neu: neutrophil granulocyte; hs-CRP: highly sensitive C-reactive protein; IL-6: 
interleukin-6; sICAM: soluble intercellular adhesion molecule; PS: P-selection; MACE: major adverse 
events; LVEF: left-ventricular ejection fraction; E/A: ratio of early (E) and atrial (A) transmitral maximal 
flow velocities; CK-MB: serial MB fraction of creatine kinase; TIMI: thrombolysis in myocardial infarction; 




(sICAM) and frequencies of coronary risk factors (history 
of diabetes mellitus and hypertension and smoking) were 
not observed (p > 0.05).  
WBC count, neutrophil granulocyte count (Neu) and PS 
level were significantly higher in the HBTF group than in 
the LBTF group (11.24 ± 3.62 vs 10.00 ± 3.35, p = 0.014; 
8.84 ± 3.42 vs 7.66 ± 3.23, p = 0.015; 13.62 ± 8.13 vs 
7.80 ± 4.17, p = 0.000) (Table 1). 
 
 
Angioplasty results and prognosis 
 
Patients in the HBTF group had a significantly lower rate 
of post-PCI TIMI grade-3 flow than that of patients in the 
LBTF group (84.52% vs 93.69%, p = 0.037). Compared 
with the LBTF group, the HBTF group had higher peak 
creatine kinase-myocardial band fraction (CK-MB) values 
(308.52 ± 215.26 vs 213.79 ± 185.27, p = 0.005), but the 
two groups had the same prevalence of major adverse 
events (Table 1). 
 
 
Prediction of HBTF 
 
Logistic regression analysis identified only the circulating 
level of PS (odds ratio (OR) 1.259, 95% confidence 
interval (CI) 1.125 - 1.408, p = 0.000) as significant 
independent predictors of HBTF on angiography. HBTF 





The results of the present study have several striking 
clinical implications. Firstly, the circulating level of PS, 
WBC count and neutrophil granulocyte count were signifi-
cantly higher in patients with HBTF than that in patients 
with LBTF. Secondly, levels of circulating PS were 
independently predictive of HBTF in the IRA. Thirdly, 
patients with HBTF in the IRA had a higher level of peak 
CK-MB and lower rate of TIMI-3 flow after PCI than that 
in patients with LBTF. The level of peak CK-MB was 
related to thrombus formation. These findings were corro-
borated by the finding that inflammatory mediators are 
frequently obtained from thrombi in human coronary 
arteries after AMI (Hoshiba et al., 2006). 
Few studies have evaluated the role of leukocyte 
subtypes in determining cardiovascular risk and the results 
are conflicting. One study demonstrated that monocytes 
have the highest predictive value (Sweetnam et al., 
1997), whereas other studies showed that neutrophils are 
the best predictors (Huang et al., 2003; Kawaguchi et al., 
1996). Recent studies with animal models showed direct 
visualization   of  neutrophilic  invasion  of  atherosclerotic  




Table 2. Stepwise logistic regression analysis of independent predictors of 
thrombus formation. 
 
Predictors Odds ratio 95% confidence interval P 
WBC (109/L) 0.807 0.516 - 1.261 0.346 
Neu (109/L) 1.356 0.851 - 2.161 0.201 
PS (ng/mL) 1.259 1.125 - 1.408 0.000 
Post-PCI TIMI-3 flow  0.598 0.152 - 2.341 0.460 
Peak CK-MB (ng/mL) 1.003 1.000 - 1.005 0.038 
 
WBC: White blood cell; Neu: neutrophil granulocyte; PS: P-selectin; TIMI: thrombolysis in 
myocardial infarction; PCI: percutaneous coronary intervention; CK-MB: serial MB 




plaques. Neutrophils may make plaques rupture more 
easily through the release of proteolytic enzymes, 
derivatives of arachidonic acid and superoxide radicals 
(Naruko et al., 2002; Li et al., 2009). The higher 
neutrophil count may not only mirror the exacerbated 
inflammatory conditions found in patients with athero-
sclerotic disease, but may also reflect the association of 
neutrophils with the instability of atherosclerotic plaques. 
The current study showed a substantially increased WBC 
count and neutrophil count in patients with thrombus 
formation compared with patients without thrombus 
formation. The suggestions presented here, which are 
based on clinical observation and laboratory findings, are 
supported by a study demonstrating that leukocyte accu-
mulation promotes fibrin deposition (Palabrica et al., 
1992). Two distinct mechanisms may explain this obser-
vation: (i) Neutrophilia as a reflection of systemic inflam-
matory status (and consequently increased cardio-
vascular risk) and (ii) lymphopenia as a reflection of the 
acute stress presented by acute coronary syndrome 
(Zazula et al., 2008). Platelet–neutrophil aggregates 
retrieved from ruptured plaques may be associated with 
an impaired coronary microcirculation and resultant myocardial 
necrosis/dysfunction. These findings underscore the 
importance of the interaction between thrombosis and 
inflammation in AMI pathogenesis (Arakawa et al., 2009). 
Accordingly, we suggest that sequestration of WBCs in 
the IRA may have had a key role in HBTF patients. Our 
findings therefore highlight the important role of the WBC 
count in assessment of the increased risk of poor 
coronary blood flow in the IRA after AMI (Schönbeck and 
Libby, 2001; Barron et al., 2000). 
Although animal and in-vitro studies have stressed the 
important role of PS in facilitating the development of 
atherosclerosis lesions (Burger and Wagner, 2003) 
mediating endothelial–leukocyte–platelet interactions 
(Hsu-Lin et al., 1984; Carlos and Harlan, 1998; Frenette 
et al., 1995; Gamble et al., 1990) and stabilizing platelet 
aggregation (Merten and Thiagarajan, 2000), data on the 
role and circulating level of soluble P-selectin (sPS) after 
AMI remains limited (Shimomura et al., 1998; Gurbel et 
al., 2001). Yip et al. (2006) found that, among AMI 
patients, the serum level of sPS was markedly higher in 
the IRA than in the systemic circulation. An increased 
level of sPS in the IRA was significantly associated with 
increased atherothrombotic burden in the IRA. This 
suggests that sPS may play a crucial part in the formation 
and organized maintenance of the thrombus in the IRA. 
This is supported by an experimental study demonstrating 
that sPS facilitates fibrin deposition within the thrombus 
(Palabrica et al., 1992. 
The present study suggested that the level of sPS is 
higher in patients with HBTF than that in patients with 
LBTF, and that this effect is an independent predictor of 
thrombus formation. Studies demonstrated that PS is 
rapidly expressed on the surface of activated platelets 
and endothelial cells after plaque rupture and thrombus 
formation in the coronary artery (Carlos and Harlan, 
1998). 
Glycoprotein P-selectin, a membrane component of 
cell-storage granules (Berman et al., 1986), is rapidly 
translocated from the a-granules of platelets and the 
Weibel–Palade bodies of endothelial cells to the cell 
surface after an inflammatory process or other stimulation 
(Hsu-Lin et al., 1984; McEver et al., 1989). Consequently, 
enzymatic cleavage of expressed PS and alternative 
splicing of the messenger ribonucleic acid of PS occur 
quickly, giving rise to sPS in the peripheral blood that can 
be detected (Ishiwata et al., 1994; Johnston et al., 1990; 
Michelson et al., 1996). The link between endothelial–
platelet–leukocyte interaction and thrombus formation is 
well recognized (Carlos and Harlan, 1998; Palabrica et 
al., 1992; Berger et al., 1998). PS expression on platelets 
in the determination of the ability and size of platelet 
aggregation has been shown in vitro (Merten and 
Thiagarajan, 2000). HBTF is usually maintained and no 
re-flow phenomena occur more frequently during late 
reperfusion time (> 240 min  3 days) (Yip et al., 2002; 
Yip et al., 2004). Studies in animal models have 
demonstrated that the infarction size of the myocardium 
can be reduced if monoclonal antibodies against PS are 
administered (Weyrich et al., 1993; Ueyama et al., 1997). 
An animal-model study demonstrated that accumulation 
of leukocytes in the thrombus (which is  mediated  by PS)  




promotes fibrin deposition (Palabrica et al., 1992). 
Another study suggested that sPS may be involved in 
modulating leukocyte recruitment or thrombus growth 
(Ueyama et al., 1997). 
The benefits of direct PCI are limited by a prevalence of 
combined slow flow (TIMI grade 2) of 5 - 20% and no-
reflow (TIMI grade 1) phenomena (Kaul et al., 1999). 
The slow-flow and no-reflow are associated with more 
extensive myocardial necrosis and consequential left-
ventricular dilatation, with poor regional and global 
contractile function and with a poor prognosis (Kern et al., 
1996; Fu et al., 2007). The putative mechanisms for 
failure to achieve normal coronary flow in the IRA include 
distal embolization of the thrombus and of debris, 
microvascular damage or edema, reperfusion injury and 
microvascular dysfunction resulting from the intervention-
induced release of lipid pool-like plaque contents (Tanaka 
et al., 2002). The present study suggests that no-
reflow/slow flow of the IRA during PCI was associated 
with thrombus formation and that the peak level of CK-
MB was higher in patients with thrombus formation than 
without thrombus formation. This supports the hypothesis 
that thrombus formation in the IRA is the most important 
factor leading to no-reflow or slow flow, increased 
myocardial necrosis and increased mortality (Yip et al., 
2002).  
There were several limitations to our study. First, this 
was a small retrospective study of patients who met strict 
entry criteria; but we believe that these criteria enabled 
us to demonstrate our results more clearly. Second, this 
study did not provide additional information with respect 
to the effect of the circulating level of these blood 





The circulating level of PS, WBC count and neutrophil 
granulocyte count were higher and PS was an independent 
predictor of the angiographic morphologic features that 





STEMI, ST-Segment elevation myocardial infarction; PS, 
P-selectin; IRA, infarct-related artery; AMI, acute 
myocardial infarction; PCI, percutaneous coronary 
intervention; HBTF, high-burden thrombus formation; 
LBTF, low-burden thrombus formation; hs-CRP, high-
sensitive C-reactive protein; IL-6, interleukin-6; sICAM-1, 
soluble intercellular cell adhesion molecule-1, WBC, 
white blood cell; TIMI, thrombolysis in myocardial 
infarction; ACS, acute coronary syndrome; RLD, 
reference lumen diameter; ELISA, enzyme-linked 
immunosorbent assay; sPS, soluble P-selectin; CK-MB, 
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